Smoothing the Dimples

What works and what’s coming in cellulite treatment technologies.
MedEsthetics Jan/Feb 2020

The firm, tight skin that patients had as children, particularly in the thighs and buttocks area, can become a distant memory as soon as they reach their late teens or early 20s. What was once picture-perfectly round and smooth often begins to acquire a sizeable collection of dimples and divots. That’s why the medical aesthetics industry has been hard at work for decades trying to eradicate the phenomenon of cellulite that impacts about 90 percent of women.

Cellfina Effective Up to Five Years

Cellulite Subcision

Merz Aesthetic’s Cellfina system for cellulite can now claim five-year benefits thanks to new clinical data and an additional clearance from the U.S. Food and Drug Administration. The clearance to update Cellfina’s indication statement from three-year benefits to five years is based on observations by an independent physician using before-and-after patient photographs at five years post-treatment. The results showed that after a single in-office treatment, 100 percent of follow-up patients still had noticeable improvements in the appearance of cellulite on the buttocks and thighs.

Chicago Cosmetic Surgery and Dermatology Joins Soliton Pivotal Cellulite Trial

Soliton, a medical device company with a novel and proprietary rapid pulse acoustic shockwave technology licensed from The University of Texas, has brought on supervising physicians Omer Ibrahim, MD, FAAD, and Carolyn I. Jacob, MD, FAAD, as well as a third study site for its upcoming expanded pivotal Cellulite Clinical Trial. The site, Chicago Cosmetic Surgery and Dermatology, joins two previously identified sites in what is anticipated to be a four-site trial.

Ultherapy With Radiesse Reduces Appearance of Cellulite

New combination treatment targets skin dimples and laxity

Patients with cellulite and skin laxity who underwent treatment with microfocused ultrasound with visualization (MFU-V; Ultherapy) in combination with diluted calcium hydroxylapatite (CaHa; Radiesse) saw a significant improvement in laxity and a significant reduction in dimpling.

Gabriel Casabona, MD, and Gregorio Pereira, MD, published the results of their retrospective study of 20 female patients (mean age: 40.0 ± 8.2 years; mean BMI 21.5 ± 1.5 kg/m2) in Plastic and Reconstructive Surgery – Global Open (July 2017).

Cellulite Reducer

Main Image: 
Cellulite Reducer

The EndyMed Contour handpiece is FDA cleared for temporary reduction in the appearance of cellulite and temporary improvement of local blood circulation, allowing for faster cell metabolism and fat elimination. It combines 3DEEP radiofrequency with an electronically controlled modulated vacuum (ECMV), modulated massage function, precise digital controls and real-time temperature tissue impedance monitoring to safely contour and tighten.

Contact: 855.363.9633, www.endymed.com.

No, don't share this with BeautyEtc
Article free tagging: 

Smooth Operators

How to manage expectations and identify the best candidates for minimally invasive and noninvasive cellulite treatment options.
Smooth Operators

Cellulite. The very word makes women—and some men—cringe. It’s a condition that affects people of all ages and body types. For decades, treatment options have been numerous and sometimes downright medieval, ranging from machines that vibrate wide canvas belts surrounding the hips and buttocks electrical muscle stimulators, mechanical massage, and a host of creams, serums and injectables. The problem: Until recently, no treatment modality has offered long-term results.

Phase 2b Trials Initiated for Injectable Cellulite Solution

Phase 2B Trials Initiated for Injectable Cellulite Solution

Pharmaceutical company Endo International has announced the initiation of its Phase 2b study of collagenase clostridium histolyticum (CCH) for the treatment of edematous fibrosclerotic panniculopathy (EFP), commonly known as cellulite. CCH (currently known as XIAFLEX) is a biologic approved in the U.S., EU, Canada, Australia and Japan for the treatment of adult Dupuytren’s contracture (DC) patients with a palpable cord, and in the U.S. and EU for the treatment of adult men with Peyronie's disease (PD).